CN107412617A - A kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof - Google Patents
A kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof Download PDFInfo
- Publication number
- CN107412617A CN107412617A CN201710664964.XA CN201710664964A CN107412617A CN 107412617 A CN107412617 A CN 107412617A CN 201710664964 A CN201710664964 A CN 201710664964A CN 107412617 A CN107412617 A CN 107412617A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- eczema
- vulva
- pregnant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 104
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 45
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 39
- 210000003905 vulva Anatomy 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 241000931705 Cicada Species 0.000 claims abstract description 13
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 241000951473 Schizonepeta Species 0.000 claims abstract description 11
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 241001093951 Ailanthus altissima Species 0.000 claims abstract description 10
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 10
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 10
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 10
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 10
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 10
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 10
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 10
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 10
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 10
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 10
- 241000576429 Forsythia suspensa Species 0.000 claims abstract description 10
- 241001598107 Imperata Species 0.000 claims abstract description 10
- 240000003146 Lobelia chinensis Species 0.000 claims abstract description 10
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 10
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 10
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 10
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 10
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 10
- 241000207929 Scutellaria Species 0.000 claims abstract description 10
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 10
- 229940116229 borneol Drugs 0.000 claims abstract description 10
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002775 capsule Substances 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 10
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 9
- 239000010440 gypsum Substances 0.000 claims abstract description 9
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000004365 Protease Substances 0.000 claims description 25
- 239000000463 material Substances 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 21
- 108091005804 Peptidases Proteins 0.000 claims description 20
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 20
- 239000000706 filtrate Substances 0.000 claims description 20
- 235000019419 proteases Nutrition 0.000 claims description 20
- 238000004659 sterilization and disinfection Methods 0.000 claims description 18
- 238000001035 drying Methods 0.000 claims description 16
- 238000007710 freezing Methods 0.000 claims description 14
- 230000008014 freezing Effects 0.000 claims description 14
- 238000000108 ultra-filtration Methods 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 241000218691 Cupressaceae Species 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 7
- 108090000526 Papain Proteins 0.000 claims description 5
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- 230000033228 biological regulation Effects 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 235000019834 papain Nutrition 0.000 claims description 5
- 229940055729 papain Drugs 0.000 claims description 5
- 238000005325 percolation Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 31
- 208000003251 Pruritus Diseases 0.000 abstract description 17
- 230000000172 allergic effect Effects 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 2
- 230000000474 nursing effect Effects 0.000 abstract description 2
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 238000003756 stirring Methods 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 9
- 208000026935 allergic disease Diseases 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 229920001184 polypeptide Polymers 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 208000030961 allergic reaction Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 206010037844 rash Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 201000005404 rubella Diseases 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 239000004575 stone Substances 0.000 description 5
- 230000005779 cell damage Effects 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001007 puffing effect Effects 0.000 description 4
- 239000002893 slag Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012434 Dermatitis allergic Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 210000002640 perineum Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000037897 vulvar eczema Diseases 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- HOMSOWZTBJWNHP-UHFFFAOYSA-N 5-chlorothiadiazole Chemical compound ClC1=CN=NS1 HOMSOWZTBJWNHP-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000605422 Asparagus asparagoides Species 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000022535 Infectious Skin disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical group C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000003029 clitoris Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- 239000002395 mineralocorticoid Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to gynecological and obstetrical nursing treatment technology field, more particularly to a kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof.Wherein endo-medicine is made up of the component of following mass fraction:57 parts of the coptis, 35 parts of Chinese lobelia, 46 parts of yncaria stem with hooks, 46 parts of coix seed, 35 parts of oriental wormwood, 46 parts of schizonepeta, windproof 46 parts, 35 parts of the root of Dahurain angelica, 57 parts of peppermint, 35 parts of cicada slough, 57 parts of golden cypress, 57 parts of radix glycyrrhizae, 35 parts of radix cynanchi bungei, 35 parts of Poria cocos, 35 parts of pollen pini.External used medicine is made up of the component of following mass fraction:35 parts of scutellaria, 57 parts of honeysuckle, 57 parts of the capsule of weeping forsythia, 35 parts of rhizoma typhonii, 35 parts of Chinese gall, 57 parts of calcined gypsum, 35 parts of the bark of the root or stem of the tree of heaven, 46 parts of radix rehmanniae recen, 12 parts of borneol, 46 parts of lalang grass rhizome.The present invention carries out the treatment of eczema of vulva and the improvement of allergic constitution using oral traditional Chinese medicine preparation, while is aided with external used medicine anti-inflammatory anti-itch, and have no side effect good effect.
Description
Technical field
The invention belongs to gynecological and obstetrical nursing treatment technology field, more particularly to a kind of Chinese medicine group for treating pregnant eczema of vulva
Compound and preparation method thereof.
Background technology
Eczema of vulva is a kind of common non-infectious skin disease, and lesion is confined to perineum and clitoris more, also even to have sprawling
To buttocks, erythema, erythema, erosion are locally may occur in which, oozes out, form a scab, furfur, course of disease length, perineum surrounding skin often thickens, color
Greyish white or dark red, coarse, so that chap occurs, oozes out, itch, recurrent exerbation are main feature, and any age can fall ill.From
From the point of view of in pathogenesis, eczema of vulva is mainly a kind of delayed allergy as caused by the inside and outside motivating factor of complexity.But
Its cause of disease to the characteristics of property, the immune response of allergen and with IgE mediation delayed response it is whether related, not yet explain completely
It is bright.
Gestational period hormone in vivo level produces great variety, and local nerve function sensitive improves therewith, and Weidner etc. is
Confirm that local nerve function sensitive improves and occur with eczema of vulva clearly related, it is interior to be in approach:Nerve fibre and hypertrophy
Cell occurs directly to contact by Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2, can make mast cell degranulation releasing histamine, cause itch.So it is different from other
Allergic dermatitis allergic eczema, even if gestational period eczema removes some sensitizing factors, eczema lesion will not disappear quickly, so existing eczema
Treatment means are for gestational vulvareczema effect and unsatisfactory.
The content of the invention
Present invention solves the technical problem that it is even if that gestational period eczema removes some sensitizing factors, eczema lesion will not be quickly
Disappear, so existing eczema treatment means are for gestational vulvareczema effect and unsatisfactory.
To solve the above problems, the present invention provides a kind of Chinese medicine composition for treating pregnant eczema of vulva, wherein medicine for oral administration
Thing is made up of the component of following mass fraction:Coptis 5-7 parts, Chinese lobelia 3-5 parts, yncaria stem with hooks 4-6 parts, coix seed 4-6 parts, oriental wormwood 3-
5 parts, it is schizonepeta 4-6 parts, windproof 4-6 parts, root of Dahurain angelica 3-5 parts, peppermint 5-7 parts, cicada slough 3-5 parts, golden cypress 5-7 parts, radix glycyrrhizae 5-7 parts, white
Tuber of multiflower knotweed 3-5 parts, Poria cocos 3-5 parts, pollen pini 3-5 parts.
Further optimization, is made up of the component of following mass fraction:6 parts of the coptis, 4 parts of Chinese lobelia, 5 parts of yncaria stem with hooks, coix seed 5
Part, 4 parts of oriental wormwood, 5 parts of schizonepeta, windproof 5 parts, 4 parts of the root of Dahurain angelica, 6 parts of peppermint, 4 parts of cicada slough, 6 parts of golden cypress, 6 parts of radix glycyrrhizae, 4 parts of radix cynanchi bungei,
4 parts of Poria cocos, 4 parts of pollen pini.
External used medicine is made up of the component of following mass fraction:It is scutellaria 3-5 parts, honeysuckle 5-7 parts, capsule of weeping forsythia 5-7 parts, white attached
Sub- 3-5 parts, Chinese gall 3-5 parts, calcined gypsum 5-7 parts, the bark of the root or stem of the tree of heaven 3-5 parts, radix rehmanniae recen 4-6 parts, borneol 1-2 parts, lalang grass rhizome 4-6 parts.
Further optimization, is made up of the component of following mass fraction:4 parts of scutellaria, 6 parts of honeysuckle, 6 parts of the capsule of weeping forsythia, rhizoma typhonii 4
Part, 4 parts of Chinese gall, 6 parts of calcined gypsum, 4 parts of the bark of the root or stem of the tree of heaven, 5 parts of radix rehmanniae recen, 1 part of borneol, 5 parts of lalang grass rhizome.
The preparation method of endo-medicine comprises the steps of:
(1) weigh Chinese medicine material by above-mentioned weight ratio, prior to 4-10 DEG C under the conditions of refrigerate 12-24h, then at -10~-18 DEG C
Lower freezing 10-20h is standby;After freezing, volumetric expansion when being frozen using hydrone, the eucaryotic cell structure of Chinese medicine is directly destroyed, is carried
High cellular damage rate, laid the first stone for the microwave bulking of next step.
(2) temperature in microwave storehouse is set as 110-130 DEG C, microwave storehouse is preheated, and then puts into 1-2kg steps (1)
Chinese medicine material after freezing processing, regulation microwave power are 450-600w, and operation 120-180s carries out microwave bulking;Then by temperature
Degree is adjusted to 40-80 DEG C, microwave power 90-120w, dries 6-9min;It is swollen that Chinese medicine after freezing is directly carried out to microwave
To change, the strength for being directly changed into the distillation of gas moment from ice using hydrone completes puffing process, does not then have to take out Chinese medicine,
Directly be dried using microwave, in dry process open stirring, Chinese medicine during stirring uniform drying and because
Microwave bulking, which is dried, to become fragile, and disintegrating slag is broken into naturally in whipping process, beneficial to the crushing in later stage.
(3) Chinese medicine after step (2) processing is put into ball mill and crushed;Further crush can cause medicinal material powder
End is homogeneous, and various active ingredients further separate out, beneficial to importing.
(4) the addition protease of the Chinese medicine material after crushing is weighed in proportion to be digested.Bioprotein after enzymolysis divides greatly
Son has been cut into small molecular protein and polypeptide, avoids allergic reaction caused by high molecular weight protein, at the same small molecular protein and
Polypeptide is more easy to absorb, and works faster.
(5) according to 1:100~1:500 solid-liquid ratio soaks ultrafiltration after 12~24h in ethanol.Pole after ethanol extracts
Property composition be readily dissolved in body fluid, be oriented to target location, it is quick;Macromolecular is further filtered in ultrafiltration, and what is left is that biology is small
Molecule, work faster.
(6) liquid after ultrafiltration is sealed after microwave disinfection.Microwave disinfection avoid high temperature sterilization to effectively into
The destruction divided, drug effect are more preferable.
Further, stage drying is used after step (2) microwave bulking, i.e., it is 70-80 DEG C to adjust temperature first, work(
Rate 110-120w, dry 2-3min;Then it is 50-70 DEG C, power 100-110w to adjust temperature, dries 2-3min;Finally adjust
Temperature is 40-50 DEG C, power 90-100w, dries 2-3min.
Further, the pulverization conditions of the step (3) are to shut down 3min, then anti-mill after 15min is just being ground using ball mill
3min is shut down after 15min, so repeatedly 2 times.
Further, the protease in the step (4) is alkali protease, neutral proteinase, papain or pancreas
One or more in protease.It is demonstrated experimentally that taking the effect of drugs after several protease hydrolyzeds of the above optimal, and pass through egg
Medicine after white enzyme enzymolysis eliminates high molecular weight protein, can prevent because of drug-induced allergy.
Further, the molecular weight that milipore filter retains in the step (5) is 15000-20000.It is demonstrated experimentally that molecular weight
It is to retain the most molecular weight of active ingredient for 15000-20000, and it is rapid-action, effect is good.
Further, step (6) the microwave disinfection condition is 70 DEG C -105 DEG C, second time 90-180.It can kill
Farthest retain active ingredient on the basis of microorganism not to be destroyed.
The preparation method of external used medicine comprises the steps of:
(1) raw mill is diluted after adding water with 60% ethanol as solvent into fine powder, using percolation, collects primary filtrate
Enter a bottle A, continue to be percolated, until filtrate is visually observed as colourless stopping;
(2) filtrate is collected, paste is concentrated under reduced pressure at 40-60 DEG C, is mixed after the primary filtrate mixing added in bottle A
Liquid;
(3) above-mentioned mixed liquor is diluted with 60% ethanol again, stands 30 hours, after filtering, obtain supernatant liquid as in this
The liquid extract of medicine.
Further, the mass ratio of described material quality and water is 1:1.
Application method:Daily oral endo-medicine, a 10-30ml, take the circumstances into consideration to be reduced according to children age, three times a day exist
External used medicine is smeared at dermexanthesis.
Toxicity Analysis:
The coptis:There are heat-clearing and damp-drying drug, purging intense heat and detonicating, cool blood bacteriostasis.Demonstrate,proved available for heat toxin sore carbuncle, eczema etc..
Chinese lobelia:There is clearing heat and detoxicating, sharp water clearing damp to act on.Available for treatment skin eczema, sore.
Yncaria stem with hooks:There are The flat liver of heat-clearing, Inflammation Zhijing effect.There is antihistamine effect.
Coix seed:Have that clearing heat and promoting diuresis, invigorating the spleen be antipruritic, diuresis apocenosis effect.Modern times are usually used in anaphylactia auxiliary treatment.
Oriental wormwood:There are clearing heat and promoting diuresis, normalizing gallbladder to cure jaundice, wind-dispelling effect.Also skin heat symptoms caused by an exopathgen can be dissipated and dispelling wind and arresting itching, for rheumatism
Condense urticaria, pruitus of skin etc..Pruitus, eczema, pruigo etc. can be treated with lotus leaf compatibility.
Schizonepeta:There is inducing sweat and dispelling exogenous evils, declare malicious promoting eruption, and blood anastalsis, go out impermeable, sore etc. for rubella pruigo, rash.With
Be the basis of dispelling wind and arresting itching prescription during windproof compatibility, available for rubella, pruitus etc. demonstrate,prove, often with frutus cnidii, smilax, cicada slough
Etc. being used cooperatively.This product can promote skin blood circulation to strengthen, and have slight antipyretic effect.Skin infection disease can be promoted
The healing of disease and the absorption of disease damage tissue.
It is windproof:There are cold dispelling solution mark, expel endogenous wind to relieve convulsion, expelling wind and relieving convulsion, itching-relieving action.For rubella of the ailment said due to cold or exposure gram in skin, addiction
Rash, sore etc. are demonstrate,proved.Often with schizonepeta compatible use.
The root of Dahurain angelica:Expel pathogenic wind from the body surface, saturating hair key, clearing the nasal passage, eliminating cold to stop pain, eliminating dampness detoxication.The kind wind for controlling head skin,
External application can treat cutaneous pruritus.This product can reduce bronchial secretion, coronary artery dilator;The suction of destroyed tissue can be promoted
Receive, play the role of to promote to absorb to chronic ulcer, scytitis or promote it to suppurate.
Peppermint:There are dispersing wind, relieving exterior syndrome, promoting qi circulation and removing obstruction in the collateral, dispelling wind and arresting itching, the effect of saturating macula.Demonstrate,proved available for pruitus, rubella etc..
It is that one of clinical herbal pair is used for general rubella, postmeasles pruitus with cicada slough, can also improves geroderma itch
And psoriasis pruritis.
Cicada slough:There are dispelling wind and heat from the body, inducing diaphoresis promoting eruption, wind-dispelling only frightened effect.Recent studies thinks that cicada slough can reduce reflex muscular
Nervous reaction, the tonicity for reducing striated muscle, there is slight blocking effect to neuromere.
Golden cypress:There are heat-clearing and damp-drying drug, purging intense heat and detonicating, nourishing Yin and falling fire effect.It is used for sore swollen toxin, eczema with rhizoma atractylodis compatibility, itches
The diseases such as rash.External application is ground with talcum, is treatment wet sore, eczema obstruction-removing prescription.
Radix glycyrrhizae:There are clearing heat and detoxicating, mediation property of medicine, expelling phlegm and arresting coughing effect, and can invigorating spleen, relieving spasm to stop pain.This product is to people
Extensive, the contained glycyrrhizin enoxolone of body effect, there is the suppression inflammation of similar cortex hormone of aadrenaline and mineralocorticoid, resist
Allergy acts on.
Radix cynanchi bungei:Bitter but sweet flavor is puckery, slightly warm in nature, nontoxic;Enter liver, kidney two warp.Effect is nourishing liver and kidney, strengthening body, and blood-nourishing is mended
Blood, crow palpus dark hair, restrains vital essence, myogenic sore, relaxes bowel.Cure mainly prolonged illness weakness, chronic wandering arthritis, soreness and weakness of waist and knees, anaemia, intestines
Bleeding, poliosis, neurasthenia, deficiency of Yin chronic malaria, ulcer do not close up long, old people constipation.
Poria cocos:With anti-oxidant, anti-aging, increase immunity, the effect of raising brain cell activity.Poria cocos has stronger
Diuresis, ephritis, heart failure oedema can be treated.There is sedation in addition, it is effective to neurasthenia.It is lightly seasoned mild-natured, it is apt to QI invigorating
Blood-nourishing, antitoxic heart-soothing and sedative, internal heat anticance;Mild in medicine property and, for dampness removing without hindering healthy tendency, contained pachymic acid has strengthen immunity, anti-swollen
Knurl and the effect of calmness, hypoglycemic etc.;Can be relaxed gastrointestinal smooth muscle, gastric acid secretion inhibiting, prevent necrosis of liver cells, antibacterial
And other effects.
Pollen pini:It is warm-natured, it is sweet.The effect of with nourishing qi and blood, soothing the liver wind-dispelling, hygroscopic, hemostasis;Head rotation dizziness is cured mainly,
Middle void has a stomach-ache, protracted dysentery, and all sores are wet rotten, traumatic bleeding.
Scutellaria:There is the effect such as help spleen soil, strengthening exterior and reducing sweat, torr sore myogenic.The blood circulation of sore tissue can be improved, promoted
The absorption or suppuration of pathological tissues.
Honeysuckle:Have clearing heat and detoxicating, antiinflammatory action, can control inflammation ooze out and inflammatory hyperplasia, leucocyte can be promoted
Phagocytic function, there is inhibitory action to a variety of pyococcus, skin infection can be controlled.
The capsule of weeping forsythia:There are clearing heat and detoxicating, dispersing swelling and dissipating binds.This product has powerful antiinflammatory and bacteriostatic functions, to aseptic inflammation
Have it is obvious it is impervious go out, reduce the effect of lesions position capillary fragility.
Rhizoma typhonii:There is the effect such as wind-dispelling slit phlegm, dredging collateral, Sweeling-eliminating medicine powder section.Fresh goods external application is smash deposited, can treat eczema.
Chinese gall:There are the puckery intestines of convergence, fall fire of astringing the lung, removing toxic substances sore.Available for eczema sore, the prolapse of uterus is wet itches
Disease.
Calcined gypsum:There are clearing heat-fire, relieving restlessness of quenching the thirst effect, capillary permeability can be reduced after for oral administration.Rear external application is forged, can
Expelling pus and promoting granulation stops blooding, for sore flowing water, eczema, burn and scald etc..
The bark of the root or stem of the tree of heaven:There are heat-clearing and damp-drying drug, hemostasis itching-relieving action.External application can treat the wet card such as itch of sore tinea.
Radix rehmanniae recen:There are clearing heat and cooling blood, the raw new role of silt of dispelling.Available for cards such as the nettle rash caused by treatment blood-head, scalls.
Borneol:Surgery makees liniment and is used for eczema, pruigo, sore prickly heat etc..
Lalang grass rhizome:There are cooling blood and hemostasis, reducing fever and causing diuresis effect.Capillary permeability can be reduced.
Constitution Theory in TCM is divided into human body the constitution of nine types.Modern Chinese medicine antiallergy laboratory current research hair
It is existing:Why allergic phenomena can occur for human body, be because the functions such as lung, spleen, kidney are disorderly and body fluid (blood, mucous membrane, jaundice
Juice, four big body fluid of black bile) it is unbalance, cause to tremble with fear, be wet, malicious savings it is internal, decline immunity of organism protection capability and cause allergy body
Matter.When in environmental stimuli material (i.e. anaphylactogen) arbitrarily invasion contact respiratory mucosa, gastrointestinal tract mucosa, skin connective tissue
Mast cell and basophil and reacting to form itch, oedema, hyperemia, a series of allergic reactions such as fester, absolutely not
General inflammation.Because allergy proper energy stimulates body to start specific immune mechanisms, and produces allergic reaction.The allergy not being avoided that
Former external cause stimulates, and allows people to feel very painful, and seeks medicine to improve symptom.Drug type mainly has:External application hormone is quick
Improving skin symptom, injection or oral Loratadine makes allergic reaction be eased, but because can not fundamentally hinder
Only abnormal allergic reaction, so can only stop just to violate, recurrent exerbation, and it can not really improve allergic constitution.Therefore want thoroughly
Anaphylactic disease is cured, must just extract cold, wet, malicious in internal organs and body fluid, adjustment spleen, kidney, the function such as lung, body fluid is adjusted and puts down
Weighing apparatus, function of immune system is recovered normal, body injury caused by repairing various allergy, thoroughly improve allergic constitution, improve people
Resistance defence capability of the body to various anaphylactogens, fine and close protection network is established on mucous membrane tissue top layer, could fundamentally be blocked
Anaphylactogen is invaded, even if running into anaphylactogen again, will not also be had an attack of one's old illness again.
The Chinese medical extract sheerly Chinese medicine preparation of the present invention, it is nontoxic and harmless to fetus and pregnant woman, pass through oral traditional Chinese medicine
Preparation carries out the treatment of eczema of vulva and the improvement of allergic constitution, while is aided with external used medicine local action, anti-inflammatory anti-itch, nothing
Side effect good effect.Wherein, the coptis, Chinese lobelia, yncaria stem with hooks, coix seed, oriental wormwood have the function that dampness removing heat-clearing;It is schizonepeta, windproof, white
The root of Dahurian angelica, peppermint, cicada slough, which have, declares malicious promoting eruption effect;Golden cypress, radix glycyrrhizae, radix cynanchi bungei, Poria cocos, pollen pini have the function that nourishing yin and nourishing blood;
Scutellaria, honeysuckle, the capsule of weeping forsythia, rhizoma typhonii, Chinese gall have the function that anti-inflammation and sterilization, and external application avoids the inflammatory reaction of allergy, forges stone
Cream, the bark of the root or stem of the tree of heaven, radix rehmanniae recen, borneol, lalang grass rhizome have the function that antipyretic and itching-stopping, alleviate discomfort caused by eczema of vulva.With 200 trouble
Exemplified by person, treated using medicine of the present invention, 198 patients are effective, and total effective rate is up to 99%;Compared to only with oral system
97 patients of agent effectively from the point of view of, effective percentage improves 50.5%;Compared to the name patient only with external used medicine 86 effectively from the point of view of,
Effective percentage improves 56%.
Embodiment
To make the purpose, technical scheme and advantage of the embodiment of the present invention clearer, below in conjunction with the embodiment of the present invention,
Technical scheme in the embodiment of the present invention is clearly and completely described, it is clear that described embodiment is the present invention one
Divide embodiment, rather than whole embodiments.Based on the embodiment in the present invention, those of ordinary skill in the art are not making
The every other embodiment obtained under the premise of creative work, belongs to the scope of protection of the invention.
Embodiment 1:
A kind of Chinese medicine composition for treating pregnant eczema of vulva, it is for oral administration to be made up of the component of following mass fraction:The coptis 6
Part, 4 parts of Chinese lobelia, 5 parts of yncaria stem with hooks, 5 parts of coix seed, 4 parts of oriental wormwood, 5 parts of schizonepeta, windproof 5 parts, 4 parts of the root of Dahurain angelica, 6 parts of peppermint, cicada slough 4
Part, 6 parts of golden cypress, 6 parts of radix glycyrrhizae, 4 parts of radix cynanchi bungei, 4 parts of Poria cocos, 4 parts of pollen pini;External used medicine by following mass fraction component group
Into:4 parts of scutellaria, 6 parts of honeysuckle, 6 parts of the capsule of weeping forsythia, 4 parts of rhizoma typhonii, 4 parts of Chinese gall, 6 parts of calcined gypsum, 4 parts of the bark of the root or stem of the tree of heaven, radix rehmanniae recen 5
Part, 1 part of borneol, 5 parts of lalang grass rhizome.
The preparation method of endo-medicine comprises the steps of:
(1) weigh Chinese medicine material by above-mentioned weight ratio, prior to 6 DEG C under the conditions of refrigerate 20h, at -15 DEG C freeze 15h it is standby
With;After freezing, volumetric expansion when being frozen using hydrone, the eucaryotic cell structure of Chinese medicine is directly destroyed, cellular damage rate is improved, is
The microwave bulking of next step lays the first stone.
(2) temperature in microwave storehouse is set as 120 DEG C, microwave storehouse is preheated, and is then put at 1kg steps (1) freezing
Chinese medicine material after reason, regulation microwave power are 500w, and operation 160s carries out microwave bulking;Then it is 60 DEG C by temperature adjustment,
Microwave power is 100w, dries 9min;Chinese medicine after freezing is directly subjected to microwave bulking, directly become from ice using hydrone
Strength for the distillation of gas moment completes puffing process, does not then have to take out Chinese medicine, is directly dried using microwave, is done
In dry process open stirring, Chinese medicine during stirring uniform drying and because microwave bulking dry become fragile, stirring
During be broken into disintegrating slag naturally, beneficial to the crushing in later stage.
(3) Chinese medicine after step (2) processing is put into ball mill and crushed;Further crush can cause medicinal material powder
End is homogeneous, and various active ingredients further separate out, beneficial to importing.
(4) the addition protease of the Chinese medicine material after crushing is weighed in proportion to be digested.Bioprotein after enzymolysis divides greatly
Son has been cut into small molecular protein and polypeptide, avoids allergic reaction caused by high molecular weight protein, at the same small molecular protein and
Polypeptide is more easy to absorb, and works faster.
(5) according to 1:300 solid-liquid ratio soaks ultrafiltration after 12~24h in ethanol.Polar component after ethanol extracts
It is readily dissolved in body fluid, is oriented to target location, it is quick;Macromolecular is further filtered in ultrafiltration, and what is left is biological micromolecule, rises
Effect is faster.
(6) liquid after ultrafiltration is sealed after microwave disinfection.Microwave disinfection avoid high temperature sterilization to effectively into
The destruction divided, drug effect are more preferable.
Stage drying is used after step (2) microwave bulking, i.e., it is 75 DEG C, power 115w to adjust temperature first, is dried
3min;Then it is 60 DEG C, power 105w to adjust temperature, dries 3min;It is 45 DEG C, power 95w finally to adjust temperature, is dried
3min。
The pulverization conditions of the step (3) are to shut down 3min after 15min is just being ground using ball mill, then are stopped after instead grinding 15min
Machine 3min, so repeatedly 2 times.
Protease in the step (4) is in alkali protease, neutral proteinase, papain or trypsase
It is one or more of.It is demonstrated experimentally that take the effect of drugs after several protease hydrolyzeds of the above optimal.
The molecular weight that milipore filter retains in the step (5) is 18000.
Step (6) the microwave disinfection condition is 85 DEG C, 160 seconds time.Can be maximum on the basis of microorganism is killed
The reservation active ingredient of degree is not destroyed.
The preparation method of external used medicine comprises the steps of:
(1) raw mill is diluted after adding water with 60% ethanol as solvent into fine powder, using percolation, collects primary filtrate
Enter a bottle A, continue to be percolated, until filtrate is visually observed as colourless stopping;
(2) filtrate is collected, paste is concentrated under reduced pressure at 50 DEG C, mixed liquor is obtained after the primary filtrate mixing added in bottle A;
(3) above-mentioned mixed liquor is diluted with 60% ethanol again, stands 30 hours, after filtering, obtain supernatant liquid as in this
The liquid extract of medicine.
Described material quality and the mass ratio of water are 1:1.
Embodiment 2:
A kind of Chinese medicine composition for treating pregnant eczema of vulva, it is for oral administration to be made up of the component of following mass fraction:The coptis 5
Part, 5 parts of Chinese lobelia, 4 parts of yncaria stem with hooks, 6 parts of coix seed, 3 parts of oriental wormwood, 6 parts of schizonepeta, windproof 4 parts, 5 parts of the root of Dahurain angelica, 5 parts of peppermint, cicada slough 5
Part, 5 parts of golden cypress, 7 parts of radix glycyrrhizae, 3 parts of radix cynanchi bungei, 5 parts of Poria cocos, 3 parts of pollen pini;External used medicine by following mass fraction component group
Into:5 parts of scutellaria, 5 parts of honeysuckle, 7 parts of the capsule of weeping forsythia, 3 parts of rhizoma typhonii, 5 parts of Chinese gall, 5 parts of calcined gypsum, 5 parts of the bark of the root or stem of the tree of heaven, radix rehmanniae recen 4
Part, 2 parts of borneol, 4 parts of lalang grass rhizome.
The preparation method of endo-medicine comprises the steps of:
(1) weigh Chinese medicine material by above-mentioned weight ratio, prior to 4 DEG C under the conditions of refrigerate 24h, at -10 DEG C freeze 20h it is standby
With;After freezing, volumetric expansion when being frozen using hydrone, the eucaryotic cell structure of Chinese medicine is directly destroyed, cellular damage rate is improved, is
The microwave bulking of next step lays the first stone.
(2) temperature in microwave storehouse is set as 110 DEG C, microwave storehouse is preheated, and is then put at 2kg steps (1) freezing
Chinese medicine material after reason, regulation microwave power are 450w, and operation 180s carries out microwave bulking;Then it is 40 DEG C by temperature adjustment,
Microwave power is 120w, dries 8min;Chinese medicine after freezing is directly subjected to microwave bulking, directly become from ice using hydrone
Strength for the distillation of gas moment completes puffing process, does not then have to take out Chinese medicine, is directly dried using microwave, is done
In dry process open stirring, Chinese medicine during stirring uniform drying and because microwave bulking dry become fragile, stirring
During be broken into disintegrating slag naturally, beneficial to the crushing in later stage.
(3) Chinese medicine after step (2) processing is put into ball mill and crushed;Further crush can cause medicinal material powder
End is homogeneous, and various active ingredients further separate out, beneficial to importing.
(4) the addition protease of the Chinese medicine material after crushing is weighed in proportion to be digested.Bioprotein after enzymolysis divides greatly
Son has been cut into small molecular protein and polypeptide, avoids allergic reaction caused by high molecular weight protein, at the same small molecular protein and
Polypeptide is more easy to absorb, and works faster.
(5) according to 1:100 solid-liquid ratio soaks ultrafiltration after 24h in ethanol.Polar component after ethanol extracts is easy to
It is dissolved in body fluid, is oriented to target location, it is quick;Macromolecular is further filtered in ultrafiltration, and what is left is biological micromolecule, works more
It hurry up.
(6) liquid after ultrafiltration is sealed after microwave disinfection.Microwave disinfection avoid high temperature sterilization to effectively into
The destruction divided, drug effect are more preferable.
Further, stage drying is used after step (2) microwave bulking, i.e., it is 70 DEG C to adjust temperature first, power
110w, dry 3min;Then it is 50 DEG C, power 110w to adjust temperature, dries 2min;It is 50 DEG C finally to adjust temperature, power
90w, dry 3min.
Further, the pulverization conditions of the step (3) are to shut down 3min, then anti-mill after 15min is just being ground using ball mill
3min is shut down after 15min, so repeatedly 2 times.
Protease in the step (4) is in alkali protease, neutral proteinase, papain or trypsase
It is one or more of.It is demonstrated experimentally that take the effect of drugs after several protease hydrolyzeds of the above optimal.
The molecular weight that milipore filter retains in the step (5) is 15000.
Step (6) the microwave disinfection condition is 105 DEG C, 90 seconds time.Can be maximum on the basis of microorganism is killed
The reservation active ingredient of degree is not destroyed.
The preparation method of external used medicine comprises the steps of:
(1) raw mill is diluted after adding water with 60% ethanol as solvent into fine powder, using percolation, collects primary filtrate
Enter a bottle A, continue to be percolated, until filtrate is visually observed as colourless stopping;
(2) filtrate is collected, paste is concentrated under reduced pressure at 40 DEG C, mixed liquor is obtained after the primary filtrate mixing added in bottle A;
(3) above-mentioned mixed liquor is diluted with 60% ethanol again, stands 30 hours, after filtering, obtain supernatant liquid as in this
The liquid extract of medicine.
Described material quality and the mass ratio of water are 1:1.
Embodiment 3:
A kind of Chinese medicine composition for treating pregnant eczema of vulva, it is for oral administration to be made up of the component of following mass fraction:The coptis 7
Part, 3 parts of Chinese lobelia, 6 parts of yncaria stem with hooks, 4 parts of coix seed, 5 parts of oriental wormwood, 4 parts of schizonepeta, windproof 6 parts, 3 parts of the root of Dahurain angelica, 7 parts of peppermint, cicada slough 3
Part, 7 parts of golden cypress, 5 parts of radix glycyrrhizae, 5 parts of radix cynanchi bungei, 5 parts of Poria cocos, 5 parts of pollen pini;External used medicine by following mass fraction component group
Into:5 parts of scutellaria, 7 parts of honeysuckle, 5 parts of the capsule of weeping forsythia, 5 parts of rhizoma typhonii, 3 parts of Chinese gall, 7 parts of calcined gypsum, 3 parts of the bark of the root or stem of the tree of heaven, radix rehmanniae recen 6
Part, 1 part of borneol, 6 parts of lalang grass rhizome.
The preparation method of endo-medicine comprises the steps of:
(1) weigh Chinese medicine material by above-mentioned weight ratio, prior to 10 DEG C under the conditions of refrigerate 12h, freeze 10h at -18 DEG C
It is standby;After freezing, volumetric expansion when being frozen using hydrone, the eucaryotic cell structure of Chinese medicine is directly destroyed, improves cellular damage rate,
Laid the first stone for the microwave bulking of next step.
(2) temperature in microwave storehouse is set as 130 DEG C, microwave storehouse is preheated, and is then put at 1kg steps (1) freezing
Chinese medicine material after reason, regulation microwave power are 600w, and operation 120s carries out microwave bulking;Then it is 80 DEG C by temperature adjustment,
Microwave power is 90w, dries 7min;Chinese medicine after freezing is directly subjected to microwave bulking, directly become from ice using hydrone
Strength for the distillation of gas moment completes puffing process, does not then have to take out Chinese medicine, is directly dried using microwave, is done
In dry process open stirring, Chinese medicine during stirring uniform drying and because microwave bulking dry become fragile, stirring
During be broken into disintegrating slag naturally, beneficial to the crushing in later stage.
(3) Chinese medicine after step (2) processing is put into ball mill and crushed;Further crush can cause medicinal material powder
End is homogeneous, and various active ingredients further separate out, beneficial to importing.
(4) the addition protease of the Chinese medicine material after crushing is weighed in proportion to be digested.Bioprotein after enzymolysis divides greatly
Son has been cut into small molecular protein and polypeptide, avoids allergic reaction caused by high molecular weight protein, at the same small molecular protein and
Polypeptide is more easy to absorb, and works faster.
(5) according to 1:500 solid-liquid ratio soaks ultrafiltration after 12h in ethanol.Polar component after ethanol extracts is easy to
It is dissolved in body fluid, is oriented to target location, it is quick;Macromolecular is further filtered in ultrafiltration, and what is left is biological micromolecule, works more
It hurry up.
(6) liquid after ultrafiltration is sealed after microwave disinfection.Microwave disinfection avoid high temperature sterilization to effectively into
The destruction divided, drug effect are more preferable.
Stage drying is used after step (2) microwave bulking, i.e., it is 80 DEG C, power 110w to adjust temperature first, is dried
2min;Then it is 70 DEG C, power 100w to adjust temperature, dries 3min;It is 50 DEG C, power 100w finally to adjust temperature, is dried
2min。
The pulverization conditions of the step (3) are to shut down 3min after 15min is just being ground using ball mill, then are stopped after instead grinding 15min
Machine 3min, so repeatedly 2 times.
Protease in the step (4) is in alkali protease, neutral proteinase, papain or trypsase
It is one or more of.It is demonstrated experimentally that take the effect of drugs after several protease hydrolyzeds of the above optimal.
The molecular weight that milipore filter retains in the step (5) is 20000.
Step (6) the microwave disinfection condition is 105 DEG C, 90 seconds time.Can be maximum on the basis of microorganism is killed
The reservation active ingredient of degree is not destroyed.
The preparation method of external used medicine comprises the steps of:
(1) raw mill is diluted after adding water with 60% ethanol as solvent into fine powder, using percolation, collects primary filtrate
Enter a bottle A, continue to be percolated, until filtrate is visually observed as colourless stopping;
(2) filtrate is collected, paste is concentrated under reduced pressure at 60 DEG C, mixed liquor is obtained after the primary filtrate mixing added in bottle A;
(3) above-mentioned mixed liquor is diluted with 60% ethanol again, stands 30 hours, after filtering, obtain supernatant liquid as in this
The liquid extract of medicine.
Described material quality and the mass ratio of water are 1:1.
Claims (10)
- A kind of 1. Chinese medicine composition for treating pregnant eczema of vulva, it is characterised in that:It is made up of endo-medicine and external used medicine, its Middle endo-medicine is made up of the component of following mass fraction:Coptis 5-7 parts, Chinese lobelia 3-5 parts, yncaria stem with hooks 4-6 parts, coix seed 4-6 Part, oriental wormwood 3-5 parts, schizonepeta 4-6 parts, windproof 4-6 parts, root of Dahurain angelica 3-5 parts, peppermint 5-7 parts, cicada slough 3-5 parts, golden cypress 5-7 parts, radix glycyrrhizae 5-7 parts, radix cynanchi bungei 3-5 parts, Poria cocos 3-5 parts, pollen pini 3-5 parts.
- 2. the Chinese medicine composition of pregnant eczema of vulva is treated as claimed in claim 1, it is characterised in that by following mass fraction Component composition:6 parts of the coptis, 4 parts of Chinese lobelia, 5 parts of yncaria stem with hooks, 5 parts of coix seed, 4 parts of oriental wormwood, 5 parts of schizonepeta, the windproof 5 parts, root of Dahurain angelica 4 Part, 6 parts of peppermint, 4 parts of cicada slough, 6 parts of golden cypress, 6 parts of radix glycyrrhizae, 4 parts of radix cynanchi bungei, 4 parts of Poria cocos, 4 parts of pollen pini.
- 3. the Chinese medicine composition of pregnant eczema of vulva is treated as claimed in claim 1, it is characterised in that external used medicine is by following The component composition of mass fraction:Scutellaria 3-5 parts, honeysuckle 5-7 parts, capsule of weeping forsythia 5-7 parts, rhizoma typhonii 3-5 parts, Chinese gall 3-5 parts, forge Gypsum 5-7 parts, the bark of the root or stem of the tree of heaven 3-5 parts, radix rehmanniae recen 4-6 parts, borneol 1-2 parts, lalang grass rhizome 4-6 parts.
- 4. the Chinese medicine composition of pregnant eczema of vulva is treated as claimed in claim 3, it is characterised in that by following mass fraction Component composition:4 parts of scutellaria, 6 parts of honeysuckle, 6 parts of the capsule of weeping forsythia, 4 parts of rhizoma typhonii, 4 parts of Chinese gall, 6 parts of calcined gypsum, 4 parts of the bark of the root or stem of the tree of heaven, 5 parts of radix rehmanniae recen, 1 part of borneol, 5 parts of lalang grass rhizome.
- 5. a kind of preparation method for the Chinese medicine composition for treating pregnant eczema of vulva as claimed in claim 1, it is characterised in that interior Medication thing comprises the steps of:(1) weigh Chinese medicine material by above-mentioned weight ratio, prior to 4-10 DEG C under the conditions of refrigerate 12-24h, it is cold at -10~-18 DEG C It is standby to freeze 10-20h;(2) temperature in microwave storehouse is set as 110-130 DEG C, microwave storehouse is preheated, and then puts into 1-2kg steps (1) freezing Chinese medicine material after processing, regulation microwave power are 450-600w, and operation 120-180s carries out microwave bulking;Then temperature is adjusted Save as 40-80 DEG C, microwave power 90-120w, dry 6-9min;(3) Chinese medicine after step (2) processing is put into ball mill and crushed;(4) the addition protease of the Chinese medicine material after crushing is weighed in proportion to be digested;(5) according to 1:100~1:500 solid-liquid ratio soaks ultrafiltration after 12~24h in ethanol;(6) liquid after ultrafiltration is sealed after microwave disinfection.
- 6. a kind of preparation method for the Chinese medicine composition for treating pregnant eczema of vulva as claimed in claim 3, it is characterised in that outer Comprised the steps of with medicine:(1) raw mill is diluted after adding water with 60% ethanol as solvent into fine powder, using percolation, collects primary filtrate and enter bottle A, continue to be percolated, until filtrate is visually observed as colourless stopping;(2) filtrate is collected, paste is concentrated under reduced pressure at 40-60 DEG C, mixed liquor is obtained after the primary filtrate mixing added in bottle A;(3) above-mentioned mixed liquor is diluted with 60% ethanol again, stands 30 hours, after filtering, obtain supernatant liquid as the Chinese medicine Liquid extract.
- 7. the preparation method of the Chinese medicine composition of pregnant eczema of vulva is treated as claimed in claim 5, it is characterised in that:It is described Stage drying is used after step (2) microwave bulking, i.e., it is 70-80 DEG C, power 110-120w to adjust temperature first, dries 2- 3min;Then it is 50-70 DEG C, power 100-110w to adjust temperature, dries 2-3min;It is 40-50 DEG C finally to adjust temperature, power 90-100w, dry 2-3min.
- 8. the preparation method of the Chinese medicine composition of pregnant eczema of vulva is treated as claimed in claim 5, it is characterised in that:It is described The pulverization conditions of step (3) are to shut down 3min after 15Min is just being ground using ball mill, then shut down 3min after instead grinding 15min, so anti- It is multiple 2 times.
- 9. the preparation method of the Chinese medicine composition of pregnant eczema of vulva is treated as claimed in claim 5, it is characterised in that:It is described Protease in step (4) is the one or more in alkali protease, neutral proteinase, papain or trypsase.
- 10. the preparation method of the Chinese medicine composition of pregnant eczema of vulva is treated as claimed in claim 5, it is characterised in that:Institute It is 15000-20000 to state the molecular weight that milipore filter retains in step (5).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710664964.XA CN107412617A (en) | 2017-08-07 | 2017-08-07 | A kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710664964.XA CN107412617A (en) | 2017-08-07 | 2017-08-07 | A kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107412617A true CN107412617A (en) | 2017-12-01 |
Family
ID=60437336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710664964.XA Withdrawn CN107412617A (en) | 2017-08-07 | 2017-08-07 | A kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107412617A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115414423A (en) * | 2022-09-26 | 2022-12-02 | 中国人民解放军海军军医大学 | Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101869626A (en) * | 2010-06-23 | 2010-10-27 | 南昌市男科医院 | Chinese medicinal compound preparation private care liquid, and preparation and application thereof |
CN103690800A (en) * | 2014-01-13 | 2014-04-02 | 刘娟 | Pregnancy vulvareczema nursing powder and preparation method thereof |
CN103721083A (en) * | 2014-01-13 | 2014-04-16 | 姜霞 | Medicinal composition for gestational vulvareczema |
CN103977162A (en) * | 2014-05-28 | 2014-08-13 | 滨州医学院附属医院 | Traditional Chinese medicament for treating gestational vulvareczema and preparation method thereof |
CN105535723A (en) * | 2015-12-25 | 2016-05-04 | 柴华 | Traditional Chinese medicinal composition for treating vulvitis and external preparation of traditional Chinese medicinal composition |
-
2017
- 2017-08-07 CN CN201710664964.XA patent/CN107412617A/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101869626A (en) * | 2010-06-23 | 2010-10-27 | 南昌市男科医院 | Chinese medicinal compound preparation private care liquid, and preparation and application thereof |
CN103690800A (en) * | 2014-01-13 | 2014-04-02 | 刘娟 | Pregnancy vulvareczema nursing powder and preparation method thereof |
CN103721083A (en) * | 2014-01-13 | 2014-04-16 | 姜霞 | Medicinal composition for gestational vulvareczema |
CN103977162A (en) * | 2014-05-28 | 2014-08-13 | 滨州医学院附属医院 | Traditional Chinese medicament for treating gestational vulvareczema and preparation method thereof |
CN105535723A (en) * | 2015-12-25 | 2016-05-04 | 柴华 | Traditional Chinese medicinal composition for treating vulvitis and external preparation of traditional Chinese medicinal composition |
Non-Patent Citations (1)
Title |
---|
刘颖: "中药内服外洗治疗外阴湿疹", 《吉林医学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115414423A (en) * | 2022-09-26 | 2022-12-02 | 中国人民解放军海军军医大学 | Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream |
CN115414423B (en) * | 2022-09-26 | 2023-09-05 | 中国人民解放军海军军医大学 | Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (en) | External traditional Chinese medicine preparation for treating refractory wound and preparation method thereof | |
CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
CN103463297B (en) | A kind of Chinese medicine composition for the treatment of eczema scrotum and its production and use | |
CN102861287B (en) | Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof | |
CN102772712B (en) | Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot | |
CN102813900B (en) | External medicine for treating foot corns | |
CN105477129A (en) | External-use plaster for psoriasis and preparation method thereof | |
CN101879267B (en) | Compound tincture for treating foot helosis | |
CN1969991A (en) | Ointment for treating skin ulcer (ulcer-treating capsule) and preparation process thereof | |
CN107213396A (en) | A kind of anti-inflammatory anti-itch washing lotion | |
CN103751309B (en) | A kind of Chinese medicine for external application treating intercostal neuralgia and preparation method thereof | |
CN107412617A (en) | A kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof | |
CN104645122A (en) | Medicine for treating toxic heat immersion type bedsore and preparation method thereof | |
CN103908600A (en) | Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof | |
CN105233152A (en) | Traditional Chinese medicinal composition having function of relieving pain and preparation method of traditional Chinese medicinal composition | |
CN104758754A (en) | Medicine for treating kidney qi deficiency benign prostate hyperplasia and preparation method thereof | |
CN1176708C (en) | Capsule for treating psora | |
CN101934016A (en) | External medicament and mineral-containing plaster for treating arthritis | |
CN105560581A (en) | Traditional Chinese medicine tincture for treating chilblain and preparation method thereof | |
CN105943976A (en) | Traditional Chinese medicinal preparation for treating intractable skin diseases and preparation method of traditional Chinese medicinal preparation | |
CN105213658A (en) | A kind of Chinese medicine lotion for the treatment of allergic eczema and preparation method thereof | |
CN104491641A (en) | Fuming and washing medicine for promoting healing of pulled muscles | |
CN105362944A (en) | Traditional Chinese medicine ointment for treating orthopedics sprain and contusion | |
CN1107692A (en) | "Xiyangning" antipruritic natural health bath lotion and its preparation | |
CN105343247A (en) | Traditional Chinese medicinal composition having function of relieving pain and preparation method of traditional Chinese medicinal composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20171201 |